AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 1 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,663,000 | +890.0% | 77,282 | +380.7% | 0.03% | +163.6% |
| Q2 2020 | $269,000 | +607.9% | 16,078 | +781.0% | 0.01% | +266.7% |
| Q3 2019 | $38,000 | +375.0% | 1,825 | +393.2% | 0.00% | – |
| Q1 2019 | $8,000 | -81.8% | 370 | -79.9% | 0.00% | -100.0% |
| Q4 2018 | $44,000 | +41.9% | 1,840 | +62.5% | 0.00% | +50.0% |
| Q3 2018 | $31,000 | -63.1% | 1,132 | -49.3% | 0.00% | -81.8% |
| Q4 2017 | $84,000 | -36.8% | 2,232 | -58.4% | 0.01% | 0.0% |
| Q3 2017 | $133,000 | +411.5% | 5,363 | +334.3% | 0.01% | +266.7% |
| Q4 2016 | $26,000 | +1200.0% | 1,235 | +734.5% | 0.00% | – |
| Q2 2016 | $2,000 | -94.9% | 148 | -94.8% | 0.00% | -100.0% |
| Q1 2016 | $39,000 | +550.0% | 2,860 | +796.6% | 0.01% | +500.0% |
| Q4 2015 | $6,000 | -94.0% | 319 | -92.0% | 0.00% | -90.0% |
| Q3 2015 | $100,000 | – | 3,964 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 3,100,146 | $117,248,000 | 40.96% |
| TLP GROUP LLC | 1,050,000 | $39,711,000 | 27.53% |
| Aisling Capital LLC | 2,240,000 | $84,717,000 | 16.74% |
| Foresite Capital Management III, LLC | 764,824 | $28,926,000 | 8.12% |
| AlpInvest Partners B.V. | 51,498 | $1,948,000 | 6.95% |
| Vivo Capital, LLC | 643,626 | $24,342,000 | 5.21% |
| GREAT POINT PARTNERS LLC | 573,550 | $21,692,000 | 3.70% |
| Eventide Asset Management | 1,226,000 | $46,367,000 | 2.42% |
| Palo Alto Investors LP | 1,146,419 | $43,358,000 | 1.87% |
| HAMILTON LANE ADVISORS LLC | 78,846 | $2,982,000 | 1.54% |